[The specificity of biochemical alterations observed following administration of radio-protective aminothiols].
D000818:Animals; D002250:Carbon Radioisotopes; D003545:Cysteine / Q000494:pharmacology* / Q000627:therapeutic use; D003864:Depression, Chemical; D007536:Isomerism; D008297:Male; D008624:Mercaptoethylamines / Q000494:pharmacology* / Q000627:therapeutic use; D011833:Radiation Injuries, Experimental / Q000188:drug therapy* / Q000201:enzymology; D011837:Radiation-Protective Agents / Q000494:pharmacology*; D051381:Rats; D013154:Spleen / Q000201:enzymology*; D013936:Thymidine / Q000378:metabolism; D013937:Thymidine Kinase / Q000378:metabolism*; D013950:Thymus Gland / Q000201:enzymology*
D002250:Carbon Radioisotopes; D008624:Mercaptoethylamines; D011837:Radiation-Protective Agents; D013937:Thymidine Kinase; D003545:Cysteine; D013936:Thymidine
K voprosu o spetsifichnosti biokhimicheskikh izmeneniĭ, nabliudaiushchikhsia pri vvedenii radiozashchitnykh aminotiolov.